Related Experiment Video
Updated: May 7, 2026

A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.
Published on: February 14, 2021
SOX4 accelerates intervertebral disc degeneration via EZH2/NRF2 pathway in response to mitochondrial ROS-dependent
Wenzhi Zhao1, Yadong Liu2, Yunxiang Hu2
1Department of Traumatic Orthopedics, The Second Affiliated Hospital, Dalian Medical University, Dalian, 116011, China.
Objective:
The transcription factor SRY-related HMG-box 4 (SOX4) has been implicated in intervertebral disc diseases. This study aimed to investigate the role of SOX4 in intervertebral disc degeneration (IDD) and explore the underlying molecular mechanisms.
Methods:
We established an IDD rat model via surgery and analyzed SOX4 expression using qRT-PCR and Western blotting. Histological evaluation, immunohistochemistry, and Safranin O staining assessed IDD progression. In vitro, an IDD cellular model was constructed using IL-1β-stimulated nucleus pulposus (NP) cells. SOX4 knockdown and overexpression experiments in NP cells examined SOX4 effects on ECM degradation, NLRP3-mediated pyroptosis, and mitochondrial ROS-dependent NLRP3 inflammasome activation. The involvement of the EZH2/NRF2 pathway in SOX4-mediated NLRP3 activation was also examined.
Results:
SOX4 expression was significantly increased in IDD rats and promoted IDD progression. Knockdown of SOX4 inhibited ECM degradation and NLRP3-mediated pyroptosis in NP cells. In vitro experiments showed that SOX4 promoted ECM degradation by upregulating MMPs and ADAMTS-5 expression, and suppressed collagen II and aggrecan synthesis. SOX4 knockdown inhibited NLRP3-mediated pyroptosis, while overexpression accelerated it in NP cells. Additionally, SOX4 was found to exacerbate mitochondrial ROS-dependent NLRP3 inflammasome activation in NP cells. Further investigation revealed that SOX4 enhanced NLRP3 inflammasome activation by upregulating EZH2 expression and modulating the EZH2/NRF2 pathway, with EZH2 inhibition attenuating SOX4-induced NLRP3 activation.
Conclusion:
Our findings suggest that SOX4 accelerates IDD progression by promoting NLRP3 inflammasome activation via modulating the EZH2/NRF2 pathway, leading to NP cell pyroptosis and ECM degradation. Targeting SOX4 may represent a potential therapeutic strategy for treating IDD.
Insights
SRY-related HMG-box 4 (SOX4) drives intervertebral disc degeneration (IDD) by activating NLRP3 inflammasomes, causing cell death and matrix breakdown. Targeting SOX4 offers a potential therapeutic approach for IDD.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Intervertebral disc degeneration (IDD) is a significant cause of back pain.
- The transcription factor SOX4 (SRY-related HMG-box 4) has been linked to IDD.
- Understanding SOX4's role is crucial for developing new IDD therapies.
Purpose of the Study:
- To investigate the role of SOX4 in intervertebral disc degeneration (IDD).
- To explore the molecular mechanisms by which SOX4 influences IDD.
- To assess SOX4's impact on extracellular matrix (ECM) degradation and nucleus pulposus (NP) cell pyroptosis.
Main Methods:
- An IDD rat model was established and SOX4 expression analyzed.
- In vitro NP cell models were used to study SOX4's effects on ECM, pyroptosis, and inflammasome activation.
- Experiments included SOX4 knockdown/overexpression, qRT-PCR, Western blotting, and histological analysis.
- The involvement of the EZH2/NRF2 pathway in SOX4-mediated NLRP3 activation was examined.
Main Results:
- SOX4 expression was elevated in IDD models and correlated with disease progression.
- SOX4 knockdown reduced ECM degradation and NLRP3-mediated pyroptosis in NP cells.
- SOX4 promoted ECM degradation by upregulating MMPs and ADAMTS-5, while suppressing collagen II and aggrecan synthesis.
- SOX4 exacerbated mitochondrial ROS-dependent NLRP3 inflammasome activation, partly via the EZH2/NRF2 pathway.
Conclusions:
- SOX4 accelerates IDD by promoting NLRP3 inflammasome activation, leading to NP cell pyroptosis and ECM degradation.
- The EZH2/NRF2 pathway is implicated in SOX4's modulation of NLRP3 activation.
- Targeting SOX4 presents a promising therapeutic strategy for IDD treatment.
More Related Videos
Related Concept Videos
Pleiotropy
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Regulation of Nuclear Protein Sorting
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Methods of Nuclear Reprogramming

